ID   INT-MEL-52
AC   CVCL_C679
SY   Me4024
DR   Wikidata; Q54897801
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=8459226;
RX   PubMed=9973437;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.1007/0-306-46872-7_16;
RA   Anichini A., Mortarini R., Vegetti C., Molla A., Borri A., Parmiani G.;
RT   "Melanoma: the Milan melanoma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.283-292; Kluwer Academic Publishers; New York; USA (1999).
//
RX   PubMed=8459226; DOI=10.1084/jem.177.4.989; PMCID=PMC2190978;
RA   Anichini A., Maccalli C., Mortarini R., Salvi S., Mazzocchi A.,
RA   Squarcina P., Herlyn M., Parmiani G.;
RT   "Melanoma cells and normal melanocytes share antigens recognized by
RT   HLA-A2-restricted cytotoxic T cell clones from melanoma patients.";
RL   J. Exp. Med. 177:989-998(1993).
//
RX   PubMed=9973437; DOI=10.4049/jimmunol.162.3.1739;
RA   Castelli C., Tarsini P., Mazzocchi A., Rini F., Rivoltini L.,
RA   Ravagnani F., Gallino F., Belli F., Parmiani G.;
RT   "Novel HLA-Cw8-restricted T cell epitopes derived from
RT   tyrosinase-related protein-2 and gp100 melanoma antigens.";
RL   J. Immunol. 162:1739-1748(1999).
//